Caplin Point Laboratories consolidated net profit rises 15.31% in the September 2026 quarter

Sales rise 17.94% to Rs 629.84 crore

Net profit of Caplin Point Laboratories rose 15.31% to Rs 178.10 crore in the quarter ended September 2026 as against Rs 154.45 crore during the previous quarter ended September 2025. Sales rose 17.94% to Rs 629.84 crore in the quarter ended September 2026 as against Rs 534.04 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	629.84	534.04	18
OPM %	35.44	35.42	-
PBDT	256.32	219.40	17
PBT	232.83	201.00	16
NP	178.10	154.45	15

Powered by Capital Market - Live News